E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 11/18/2005 in the Prospect News Biotech Daily.

Hythiam full greenshoe exercised, raising follow-on sale to $43.7 million.

By Ted A. Knutson

Washington, Nov. 18 - Hythiam, Inc. said bookrunner UBS Securities LLC exercised the full over-allotment provision of the company's recent follow-on offering, agreeing to purchase an additional 1.2 million shares at $4.75 per share, according to an 8-K filing with the Securities and Exchange Commission.

Proceeds to the company from the greenshoe are $5.7 million.

The greenshoe was expected to close Friday.

Hythiam originally issued 8 million shares at $4.75 each in a follow-on offering on Nov. 2, raising $38 million.

Los Angeles-based Hythiam makes physiological protocols designed to treat substance dependence.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.